🇯🇵·1d agoIndustry
アバスチン、神経線維腫症2型に対する世界初の治療薬として、適応追加の承認を取得
Publisher
C
Chugai Pharmaceutical News
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Chugai Pharmaceutical News
- Region
- Japan
- Scope
- Industry
- Published
- June 19, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on chugai-pharm.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Chugai Pharmaceutical News
Scope: Industry